| XOMA Royalty Corporation: XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab | - Takeda regains a majority of XOMA Royalty's royalty interest in mezagitamab (TAK-079) -- XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine... ► Artikel lesen |
| Takeda Canada: British Columbia Now Reimburses FRUZAQLA | TOKYO (dpa-AFX) - Takeda Canada announced that FRUZAQLA - fruquintinib capsules - will now be reimbursed by BC Cancer as a treatment option for adult patients with metastatic colorectal cancer... ► Artikel lesen |
| Protagonist And Takeda Report 52-Week Rusfertide Data In Polycythemia Vera | TOKYO (dpa-AFX) - Protagonist Therapeutics, Inc. (PTGX) and Takeda (TAK) announced new 52-week results from the pivotal Phase 3 VERIFY study of rusfertide in patients with polycythemia vera... ► Artikel lesen |
| Innovent, Takeda Close $11.4 Bln Collaboration To Advance Next-Generation IO And ADC Therapies | BEIJING (dpa-AFX) - Innovent Biologics (IVBXF, 1801.HK) announced that its global strategic collaboration with Takeda (4502.T, TAK) has officially closed and become effective following the satisfaction... ► Artikel lesen |
| Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies | SAN FRANCISCO and SUZHOU, China, Dec. 4, 2025 /PRNewswire/ -- Innovent Biologics (HKEX: 01801) today announced that the global strategic collaboration with Takeda... ► Artikel lesen |
| Historisches Hyogo: Takeda-jo ist das "Machu Picchu Japans"/ Die Präfektur Hyogo in der Setouchi-Region zieht mit Burgen, Blüten, Beef und Brauereien Japanreisende in ihren Bann | Frankfurt am Main/Setouchi Region (ots) - Wer die Präfektur Hyogo im Osten der Setouchi-Region bereist, entdeckt ein Stück Japan voller Genuss und Geschichte. Etwa in den Bergen von Asago, wo sich die... ► Artikel lesen |